
    
      To determine how many patients are referred for sudden cardiac death (SCD) risk
      stratification and management, indicated for implantable cardioverter defibrillator (ICD), or
      cardiac resynchronization therapy- defibrillator (CRT-D) implant, and how many receive such
      devices within 12 months of experiencing an MI.
    
  